UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000024685
Receipt No. R000025929
Official scientific title of the study Efficacy of daiobotampito in the treatment of acute diverticulitis of colon: a single-center open-label randomized controlled trial
Date of disclosure of the study information 2016/12/01
Last modified on 2017/04/05 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy of daiobotampito in the treatment of acute diverticulitis of colon: a single-center open-label randomized controlled trial
Title of the study (Brief title) Trial about efficacy of daiobotampito in the treatment of acute diverticulitis
Region
Japan

Condition
Condition diverticulitis of colon
Classification by specialty
Gastroenterology Infectious disease
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of efficacy of daiobotampito in the treatment of diverticulitis
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Phase III

Assessment
Primary outcomes Visual analogue scale (VAS) of abdominal pain on day 3
Key secondary outcomes VAS of abdominal pain other than day 3
Day on which VAS of pain becomes equal to or less than 50 mm
Frequency of stool
Frequency of ingravescence of diverticulitis, which patients need operation
Frequency of adverse event

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Patients are treated with fasting, antibacterial agents, and 7.5g per day of daiobotampito extract (Tsumura co.) for 10 days or not.
Interventions/Control_2 Patients are treated with fasting, antibacterial agents. They are not treated with daiobotampito extract.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria Patients with diverticulitis who have strong pain (VAS > 50mm)
Key exclusion criteria High probability to perforate.
Diarrhea or soft stool.
Chronic appetite loss, abdominal pain or diarrhea.
Too friable.
Insulin use.
Immuno-compromised host.
Pregnant or puerperal.
Kidney disease (eGFR < 20 ml/min/1.73m^2).
Allergy to daiobotampito.
Experience to join in this trial before.
Doctor's diagnosis as inappropriate.
Target sample size 60

Research contact person
Name of lead principal investigator Nakazawa, Atsushi
Organization Tokyo Saiseikai Central Hospital
Division name Gastrointestinal Medcine
Address Mita 1-4-17, Minato-ku, Tokyo, Japan 108-0073
TEL 03-3451-8211
Email anakaza@b-star.jp

Public contact
Name of contact person Koike, Hiroshi
Organization Tokyo Saiseikai Central Hospital
Division name General Internal Medcine
Address Mita 1-4-17, Minato-ku, Tokyo, Japan 108-0073
TEL 03-3451-8211
Homepage URL
Email koike-h@umin.ac.jp

Sponsor
Institute Gastrointestinal Medcine, Tokyo Saiseikai Central Hospital
Institute
Department

Funding Source
Organization Keio University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Center for Kampo Medicine, Keio University School of Medicine
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 12 Month 01 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2016 Year 12 Month 01 Day
Anticipated trial start date
2016 Year 12 Month 02 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 11 Month 02 Day
Last modified on
2017 Year 04 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025929